INTRODUCTION
============

Transient receptor potential (TRP) channels are highly conserved transmembrane protein channels present in organisms, ranging from worms to mammals ([@b89-molce-42-569]). These cationic channels were first characterized in the vinegar fly, *Drosophila melanogaster*. While a visual mechanism using forward genetic screening was being studied, a mutant fly showed a transient response to constant light instead of the continuous electroretinogram response recorded in the wild type ([@b16-molce-42-569]). Therefore, the mutant was named as *transient receptor potential* (*trp*). In the beginning, researchers had spent two decades discovering the *trp* locus with the germ-line transformation of the genomic region ([@b52-molce-42-569]). Using a detailed structural permeation property analysis in light-induced current, the TRP channel was confirmed as a six transmembrane domain protein, bearing a structural resemblance to a calcium-permeable cation channel ([@b52-molce-42-569]). This channel system shows structural resemblance with voltage-gated cation channels but largely different in composition of the positively charged amino acid residues which determines voltage sensing ([@b55-molce-42-569]). So far, about 100 *trp* genes have been reported in many animals ([@b59-molce-42-569]). TRP channels are subdivided into two groups and seven subfamilies: Group 1 includes TRPC (canonical, C1--C7), TRPV (vanilloid, V1--V6), TRPM (melastatin, M1--M8), TRPA (ankyrin, A1), and TRPN (NOMP-like). Group 2 includes TRPP (polycystin, P1--P5) and TRPML (mucolipin, ML1--ML3) ([@b58-molce-42-569]).

The ancient TRP channels which are present in protists, chlorophyte algae, choanoflagellates, yeasts, and fungi are primarily involved in chemosensory, thermosensory, or mechanosensory functions ([@b49-molce-42-569]; [@b98-molce-42-569]). Many of these functions are remarkably conserved and can be found in various groups, including protists, worms, flies, and humans ([@b51-molce-42-569]). TRP channels are involved in diverse physiological functions, ranging from sensation (pheromone signaling, visual, auditory, and taste transduction, nociception, and temperature sensation) to motility (muscle contraction and vaso-motor control). Furthermore, TRP channels are the key participants in the regulation of gut motility, mineral absorption, blood circulation, bladder and airway hypersensitivities, body fluid balance, cell growth, and survival ([@b59-molce-42-569]; [@b87-molce-42-569]).

Metabolism and glucose homeostasis are tightly regulated processes ([@b96-molce-42-569]). The central nervous system (CNS) incorporates both central and peripheral signals for the coordinated control and modulation of food consumption, glucose homeostasis, and energy expenditure. However, *in vivo* study of physiological roles of TRP channels expressed in the CNS is still insufficient. Around 30 TRP channels are documented to be expressed in the digestive system. They are involved in taste, gastrointestinal movement, absorption, secretion, and maintenance of mucosal homeostasis ([@b23-molce-42-569]; [@b37-molce-42-569]). Interestingly, involvement of various hormones and neurotransmitters alter the activity of channel system that controls the neuronal functions in the central regulation of metabolism ([@b10-molce-42-569]). Combined studies using mouse genetics, together with neuroanatomical methods and electrophysiological examination, have provided new findings about the roles of various ion channels that modulate neurons associated with metabolism and related disorders ([@b77-molce-42-569]).

TRP channels are present in various metabolically important tissues. They are widely expressed in the pancreatic cells, liver, gastrointestinal tract ([@b103-molce-42-569]), skeletal muscle, kidney, adipose tissue, heart, vasculature, and nervous system ([@b106-molce-42-569]). Although TRP channels and their ligands are potential targets to treat obesity and diabetes in the field of metabolic diseases ([@b60-molce-42-569]), their roles in many metabolic processes are still controversial and being studied. Here we discuss the role of TRP channels in metabolism and suggest numerous avenues for future study.

TRP CHANNELS IN METABOLISM
==========================

Members of the TRP channels play important physiological roles and can be observed in cells in different metabolic states. They work as gatekeepers for the trans-cellular transport of several cations, including Ca^2+^ and Mg^2+^, but their biological roles are diverse ([Table 1](#t1-molce-42-569){ref-type="table"}) ([@b58-molce-42-569]).

TRPA
----

TRPA1 is a receptor for a broad range of environmental oxidants and irritants and has a central role in pain and other preclinical conditions ([@b27-molce-42-569]). It is directly activated by cinnamaldehyde, allyl isothiocyanate (AITC), allicin, formalin, and icilin ([@b8-molce-42-569]; [@b46-molce-42-569]; [@b86-molce-42-569]). In association with cinnamaldehyde, TRPA1 drives insulin and ghrelin secretion, enhances insulin sensitivity in the CNS and reduces the deposition of fat in the liver. Supplementing AITC with a high-fat diet causes less weight gain compared with high-fat diet alone in mouse model ([@b1-molce-42-569]). *Drosophila* TRPA1 (dTRPA1) is highly expressed in the posterior dorsal ganglion of the fly brain and the axon bundles of the place are sent to the sub-esophageal zone, which is a primary center to regulate feeding ([@b38-molce-42-569]). This indicates possible direct control in metabolism of dTRPA1 in brain. Non-targeted metabolomic profiling revealed that mutations in dTRPA1 had a direct effect on the free fatty-acid metabolism and methionine salvage pathway. Furthermore, trehalose is a sugar associated with cellular processes for heat protection. This process is slightly upregulated in a *trpA1* mutant background ([@b37-molce-42-569]). TRPA1 has a role in enteroendocrine L-cells of the intestine. The gut hormone, glucagon-like peptide 1 (GLP-1) has a crucial role in glucose metabolism. It acts via changing insulin secretion on the gut--brain axis. Administration of TRPA1 into the duodenum resulted in GLP-1 secretion from these cells. So higher levels of GLP-1 can be an alternative hallmark in antidiabetic therapy ([@b76-molce-42-569]). TRPA1 is also expressed in enterochromaffin cells that contain cholecystokinin (CCK). The activation of TRPA1 causes satiety in mice via CCK secretion ([@b61-molce-42-569]). Methyl syringate, one of the TRPA1 agonists, decreases food ingestion and gastric emptying in mouse models ([@b30-molce-42-569]). However, TRPA1 is also expressed in the tongue of mammals and insects ([@b31-molce-42-569]; [@b99-molce-42-569]). It is possible that TRPA1 agonists can directly activate taste receptor cells to reduce ingestion. So it is combinatory effect in pheripheral as well as internal sensors.

TRPV
----

The TRPV channel subfamily has six members categorized into two groups: TRPV1--V4 and TRPV5--V6. TRPV1--V4 consists of the thermo-TRPs that are triggered by specific temperature threshold. Although TRPVs that are thermosensitive seem to function in sensing temperature changes, these channels are also present in tissues where dramatic temperature swings are prevented by thermoregulatory homeostasis. Thus, temperature may perform a permissive rather than essential role in controlling the activity of these TRPs ([@b45-molce-42-569]; [@b53-molce-42-569]). TRPV5 and TRPV6 have a role to reabsorb Ca^2+^ from the kidney and intestine, respectively ([@b57-molce-42-569]).

TRPV1 has a role in potential sensory nerves that innervate into pancreatic islets and adipose tissues for insulin production. These channels are expressed in several neuronal (from olfactory, basal ganglion to cerebellum) and non-neuronal (buccal cavity, intestine, stomach, liver, and pancreas) cells ([@b60-molce-42-569]; [@b74-molce-42-569]). TRPV1 channel is activated by temperature threshold around 42°C, and hot pepper ingredient, capsaicin. Ingestion of capsaicin, the well-known TRPV1 agonist, prevents diet-induced obesity in mouse models ([@b29-molce-42-569]). Adipose tissue expresses TRPV1, but the tissue isolated from obese animals including humans displayed reduced expression level of TRPV1 ([@b14-molce-42-569]; [@b105-molce-42-569]). TRPV1 knock-out (KO) mice developed age-associated obesity and hypo-metabolism ([@b92-molce-42-569]). However, recent findings have indicated that the prevention of obesity as beneficial effects seem to be minute and would in all probability require daily long-term intake of capsaicin ([@b73-molce-42-569]; [@b95-molce-42-569]). While consuming a standard chow diet, TRPV1 KO mice showed normal insulin sensitivity, with comparable glucose metabolism rates to wild-type mice ([@b36-molce-42-569]). Interestingly, TRPV1 KO mice were also protected from obesity caused by diet and exhibited an increased longevity, which correlated with the prolongation of a juvenile metabolic profile ([@b56-molce-42-569]).

In addition, TRPV1 is found to participate in multifaceted metabolic functions in various other tissues, including the adipose tissue, hypothalamus, and the gastrointestinal tract ([@b2-molce-42-569]). However, the exact roles underlying their protective functions in these tissues remain obscure. Relying on the metabolic state and cell type, TRPV1 has been a positive inducing factor for metabolic homeostasis. Activation of TRPV3 triggers inhibition of the phosphorylation of insulin receptor substrate-1 (IRS-1) and suppression of PPAR-γ, thus preventing lipid accumulation and adipogenesis ([@b3-molce-42-569]; [@b4-molce-42-569]; [@b101-molce-42-569]). In brown adipose tissue (BAT), activation of TRPV4 negatively operates oxidative metabolism ([@b101-molce-42-569]). The loss of TRPV4 results in a rise of oxidative potential in skeletal muscle by a compensatory regulatory mechanism ([@b34-molce-42-569]). Interestingly, creating TRPV4 KO mice or antagonizing TRPV4 by pharmacologic blockade with glibenclamide elevates thermogenesis in adipose tissue and protects against adipose inflammation, diet-mediated obesity, and insulin resistance. TRPV4 in adipose tissue boosts pro-inflammatory cytokines ([@b5-molce-42-569]; [@b101-molce-42-569]).

TRPM
----

The TRPM subfamily is composed of eight members, which are categorized into three groups based on their structural homology: TRPM1/3, TRPM4/5, and TRPM6/7. TRPM2 and TRPM8 have relatively low sequence homology with the others and therefore they are not included in the group. TRPM2, TRPM6, and TRPM7 are distinctive among other TRPM channels because they have active enzyme domains in their C-termini merged to their transmembrane domains ([@b54-molce-42-569]; [@b91-molce-42-569]). TRPM2, TRPM3, TRPM4, and TRPM5 have been distinguished to contribute in the regulation of metabolism ([@b106-molce-42-569]).

TRPM2, TRPM3, TRPM4, and TRPM5 are present in rodent insulinoma cells and mouse islets. TRPM2, TRPM4, and TRPM5 have a role in the regulation of insulin secretion. TRPM2 and TRPM4 channels are present in insulin-producing pancreatic β-cells, and expression of dominant negative forms of TRPM4 and TRPM2 small interfering RNAs (siRNAs) decreases insulin secretion from the β-cells ([@b12-molce-42-569]; [@b21-molce-42-569]; [@b32-molce-42-569]; [@b85-molce-42-569]). TRPM5 is also important for Ca^2+^-activated cation channels in β-cells and GLP-1 secreting L-cells. Much like the TRPV1, the TRPM8 channel has a role in adipocytes ([@b19-molce-42-569]; [@b64-molce-42-569]; [@b72-molce-42-569]). Menthol is a known TRPM8 agonist which induces hyperactivity and suppresses diet-induced weight gain ([@b26-molce-42-569]; [@b65-molce-42-569]). Menthol amplifies uncoupling protein 1 (UCP-1) expression in BAT in a dose-dependent way. However, this effect disappears in TRPM8 KO mice. Mice can be prevented from diet-induced obesity through prolonged dietary menthol supplements. In humans, TRPM8 activation can induce the browning of white adipose tissue (WAT browning), possibly by accelerating energy consumption ([@b72-molce-42-569]).

TRPM2 KO mice have deficits in insulin production under both high-fat or normal diet ([@b88-molce-42-569]). TRPM2 is broadly expressed in organs including the heart, brain, kidney and the immune system. It also functions as an oxidative stress sensor ([@b25-molce-42-569]; [@b66-molce-42-569]). Moreover, TRPM2, TRPM4, and TRPM5 are controlled via CNS and have roles in neuronal activation, neurodegeneration, and cell death ([@b69-molce-42-569]).

FUNCTIONAL CHARACTERISTICS OF TRP CHANNELS
==========================================

Lipid metabolism
----------------

TRP channels have been shown to be key regulatory proteins involved in the process of lipid metabolism and energy homeostasis ([@b106-molce-42-569]). TRPV1 activation by capsaicin induces decreased triglyceride amounts in 3T3-L1 pre-adipocytes during adipogenesis. Similarly, capsaicin reduces dietary high-fat-induced hypertriglyceridemia in rats by exhibiting higher lipoprotein lipase movement in adipose tissues ([@b82-molce-42-569]). Depending on the membrane lipid content, the localization, and function of TRP channel can be controlled. When methyl-β-cyclodextrin was treated in rat arteries as the cholesterol acceptor, membrane cholesterol is reduced, and *trpC1* expression level is decreased ([@b6-molce-42-569]). Similarly, cholesterol depletion in adult rat DRGs reduces TRPV1 levels in membrane, which induces decrease of TRPV1 currents mediated by proton or capsaicin ([@b43-molce-42-569]). Furthermore, lysophosphatidylcholine (LPC) derived from phosphatidylcholine in cell membrane activates TRPC6 in cultured human corporal smooth muscle cells. LPC is one of major phospholipids of oxidized low density lipoprotein (LDL), which is an active pro-inflammatory lipid in pathological conditions ([@b68-molce-42-569]). Moreover, LPC and lysophosphatidylinositol (LPI) are able to induce TRPV2 activation. This activation mediated by Gq/Go and phosphatidylinositol-3,4 kinase (PI3,4K) signaling, seems to be mostly attributable to TRPV2 localization to the plasma membrane. It is highly dependent on the lysophospholipid head group and the length of the side-chain. In prostate cancer, metastasis of the cells is increased by TRPV2 activation by LPC and LPI ([@b50-molce-42-569]). This may suggest a pathological role of TRPV2. Furthermore, 7-ketocholesterol, as a component of oxidized LDL, induces TRPC1 translocation to lipid rafts, activation of the channel, and increased calcium influx ([@b7-molce-42-569]).

Some studies have highlighted differences in intracellular Ca^2+^ concentration among normal and insulin-resistant cardiomyocytes by the application of bipolar lipids. Exogenous polyunsaturated fatty acids (PUFAs) bypass endogenous synthesis of PUFAs by eliciting TRPV1-dependent Ca^2+^ inward currents in sensory neurons ([@b28-molce-42-569]; [@b35-molce-42-569]). Both cholesterol and sphingolipids as raft-enriched lipids may have effects on TRP channel activity, either via direct protein-lipid interactions or by affecting the physical properties of the lipid bilayer ([@b17-molce-42-569]). Lipid signaling and lipotoxicity are strongly connected with oxidative metabolism. As a result, lipid agonists or modulators of TRPC channels are subject to oxidative modification ([@b80-molce-42-569]).

Glucose metabolism
------------------

Hyperglycaemia significantly increases TRPC6 in platelets, whereas expression of other TRPC members remain the same ([@b42-molce-42-569]). GLUT4 is a glucose transporter protein, which is highly expressed in mammalian adipose tissues and skeletal muscles ([@b24-molce-42-569]). Unlike other cohorts of glucose transporters, GLUT4 responds efficiently to insulin. A variety of genetically engineered mouse models have been used to demonstrate the role of GLUT4 in maintaining whole body metabolism, including glucose homeostasis in muscles and energy sensors in adipocytes. However, GLUT4 KO mice show normal fat mass and adipocyte size, and normal glucose uptake in adipose tissues. GLUT4 is an energy sensor rather than a main regulator of glucose homeostasis in adipocytes ([@b102-molce-42-569]). Interestingly, TRPV1 KO mice showed longer life spans, with juvenile metabolic phenotypes, when their diet was supplemented with capsaicin, suggesting TRPV1 may cause diet-induced obesity in mice ([@b71-molce-42-569]). In contrast, TRPM8 activation via diet supplements in mice was protective against diet-induced obesity ([@b72-molce-42-569]).

METABOLIC SYNDROME
==================

TRP channels are widely present in the tissues including adipocytes, endothelial cells and vascular smooth muscles. So the deficits of TRP channels are highly related to numerous diseases and specifically related with the progression of varied cardiovascular diseases ([@b59-molce-42-569]). This explains their widespread functions. However, because they are widely distributed, disturbance in or alterations in expression of TRP channels may induce the development of metabolic syndrome ([Table 2](#t2-molce-42-569){ref-type="table"}). Multiple channels such as TRPV1, TRPC3, TRPC6, and TRPC7 are activated essentially by diacylglycerol, whereas other TRPCs such as TRPC4, TRPC5, and TRPC6 are mainly activated after exhaustion of intracellular sarcoendoplasmic stores ([@b59-molce-42-569]). TRP channels may be directly affected by the agonists that were involved in the pathology of metabolic syndrome. For instance, angiotensin receptors are activated by angiotensin II. Series of ligand dependent activation cascade finally lead to the production of inositol triphosphate and diacylglycerol from phosphoinositide. These are the keys to open TRP channels, as elevation of diacylglycerol and depletion of inositol trisphosphate stores activate TRP channels ([@b9-molce-42-569]). The hetero-multimeric composition and expression of TRP channels maintain balance in the intracellular calcium homeostasis via transmembrane calcium influx. These functional alterations may develop metabolic syndromes ([@b41-molce-42-569]).

Obesity
-------

Obesity is the abnormal increase in body weight, as a sign of many of metabolic syndromes ([@b22-molce-42-569]). The TRPV1 channel is a key regulator of pre-adipocytes, appetite regulation, fat distribution, and obesity-induced chronic inflammatory responses. Both endogenous agonists (N-arachidonoyl dopamine and anandamide) and exogenous agonists (capsaicin and resiniferatoxin) may influence TRPV1 channel activity ([@b33-molce-42-569]). Application of capsaicin prevents adipogenesis and obesity in both mice and humans. Capsaicin increases intracellular calcium in pre-adipocytes but not in mature adipocytes, which is highly dependent on TRPV1 expression between pre-adipocytes and mature adipocytes ([@b100-molce-42-569]; [@b104-molce-42-569]). However, when mice were fed on a high-fat diet, weight gain did not differ between TRPV1 KO and wild-type mice ([@b47-molce-42-569]). Moreover, ingestion of capsaicin with a high-fat diet did not block obesity in TRPV1 KO mice, although it affected obesity in wild-type ([@b104-molce-42-569]). This finding may be explained by another study that showed the phenotype of TRPV1 KO mice is dependent on age and environmental variables that have direct impact on thermoregulation ([@b94-molce-42-569]).

TRPV1 is expressed in visceral adipose tissues expressed in visceral as well as pre-adipocytes. When mice is fed with high sugar (high diet food) supplemented with TRPV1 agonist mono-acyl glycerol, it prevents white fat accumulation, activating mitochondrial UPC1 in BAT. Comparing obese male mice with their lean counterparts, the level of TRPV1 is alleviated in visceral tissues. Moreover, ingestion of capsaicin with a high fat diet did not block obesity in TRPV1 KO mice, although it affected obesity in wild type ([@b104-molce-42-569]). This activation of TRPV1 leads to PPAR-γ activation, nuclear factor NF-kB inactivation, the secretion of pro-inflammatory mediators by macrophage activation, and inhibition of obesity-associated macrophage migration. The obesity induced chronic inflammatory responses have major role in the developmental process of atherosclerosis and type II diabetes mellitus (T2DM) ([@b48-molce-42-569]). Endogenous TRPV1 agonist, N-oleoylethanolamide activates vagal sensory afferent neurons that regulate calorie intake and appetite. This phenomenon is investigated only in wild type mice, because only wild type mice showed decreased food consumption, suggesting that TRPV1 activation may control appetite ([@b93-molce-42-569]).

Some TRPV members (V1--V4) have been proven to play pivotal roles in adipocytes. TRPV3 is highly expressed in adipocytes, and its activation prevents lipid buildup and adipogenesis ([@b13-molce-42-569]; [@b67-molce-42-569]). In contrast, only TRPV1, TRPV2, and TRPV4 may have roles in 3T3-F442A pre-adipocytes. TRPV4 is highly expressed in this cell line, which confirms previous observation that exhibit TRPV4 expression in adipose tissue ([@b40-molce-42-569]). Subcutaneous adipose tissue of TRPV4 KO mice showed higher UCP1 levels compared with control mice. Taken together, TRPVs results in having significant functions in adipocytes ([@b79-molce-42-569]; [@b107-molce-42-569]).

TRPM5 is a common downstream ion channel in type 2 taste receptor cells for GPCRs, which sense the basic tastes of sweet, umami, and bitter ([@b78-molce-42-569]). Genetic changes in TRPM5 completely impaired the ability of mice to detect not only various tastes but also fat ([@b44-molce-42-569]). Blocking TRPM5 in taste cells reduces appetite, so it can be a strategy to lose weight ([@b63-molce-42-569]; [@b62-molce-42-569]; [@b78-molce-42-569]). Quinine as a TRPM5 blocker induces weight loss in a mouse model ([@b11-molce-42-569]). Similarly, but inversely, levels of the fat hormone, adiponectin, are correlated with the amount of fat. Thus, overexpression of adiponectin increases energy expenditure and as a result, induces a lean body type. Blocking TRPC5 channels results in increase of plasma adiponectin, which can be beneficial to patients with metabolic disorders such as obesity and T2DM ([@b63-molce-42-569]).

Diabetes
--------

It is experimentally proven that several TRP channels have a practical role in the onset of diabetes mellitus ([@b41-molce-42-569]). Among different TRPVs, TRPV1 has been found to control islets inflammation and insulin resistance by activating its associated pancreatic sensory neurons. Ablating TRPV1-associated pancreatic sensory neurons in diabetes-prone mice prevents developing diabetes and insulitis. This indicates that pathogenesis of type I diabetes mellitus is associated with TRPV1 activation ([@b70-molce-42-569]). Insulin signaling promotes mitochondrial oxidative capacity and ATP production. TRPA1 is abundant in rat pancreatic β cells ([@b15-molce-42-569]). TRPA1 agonists such as mustard oil and 4-hydroxy-2-nonenal induce insulin secretion in pancreatic β cells. Furthermore, the TRPA1 antagonist including HC-030031 hinders insulin release induced by glucose increase. This provides the evidence that TRPA1 has a direct role to control insulin secretion ([@b39-molce-42-569]).

TRPM2 activation induces calcium increase into pancreatic islets, and increases in the level of cyclic ADP-ribose. This results in regulating insulin secretion ([@b85-molce-42-569]). Reactive oxygen species (e.g., H~2~O~2~), glucose, and incretins are stimuli for the activation of TRPM2 ([@b88-molce-42-569]). TRPM2 KO mice are more sensitive to insulin because of increased glucose metabolism in their heart arising from the phosphorylation of elevated Akt and glycogen synthase kinase 3. TRPM2 KO mice also reduce inflammation in the adipose tissue and liver ([@b105-molce-42-569]). These evidences demonstrate that TRPM2 has a role in metabolism. Expression of TRPM2, TRPM4, and TRPM5 has been found in human islets of Langerhans, suggesting that they may regulate pancreatic function and insulin secretion ([@b15-molce-42-569]; [@b81-molce-42-569]).

Mucolipidosis
-------------

Lysosomal storage disorders are metabolic diseases characterized by a deficiency in the enzymes that are important for vesicular lipid, carbohydrate, and protein metabolism ([@b20-molce-42-569]). Four types of mucolipidosis have been identified based on their physiology and pathophysiology ([@b18-molce-42-569]). Mucolipidosis type IV (MLIV) is an autosomal recessive disorder, generated by mutations in transient receptor potential mucolipin 1 (TRPML1). In MLIV, TRPML1, a vesicular Ca^2+^ release channel, is non-functional. TRPML1 contributes to the fusion of amphisomes with lysosomes. Other types of mucolipidosis are caused by non-functional metabolic enzymes. These include mucolipidosis I (sialidosis), caused by aberrant sialidase, and mucolipidosis II and III, caused by mutated N-acetylglucosamine-1-phosphotransferase ([@b75-molce-42-569]; [@b84-molce-42-569]; [@b83-molce-42-569]). In *Drosophila*, a null mutation of *trpml* leads to pupal lethality, when the flies count to autophagy for nutrition. This pupal lethality is caused by reduced targets of rapamycin complex 1 (TORC1) signaling ([@b90-molce-42-569]). This indicates that cellular amino acid starvation is one of the fundamental causes of toxicity in the TRPML deficiency. It raises the intriguing feasibility that neurological disorder in MLIV patients may therefore stem from amino acid deprivation. A high-protein diet can reduce pupal lethality and increase the amount of acidic vesicles. However, further inhibition of TORC1 activity by administering rapamycin worsens the *trpml* mutant phenotype. The severity of MLIV might be decreased with a high-protein diet ([@b97-molce-42-569]).

CONCLUSION AND FUTURE PERSPECTIVES
==================================

TRP channels possess various metabolic functions which are thought to be key targets for different physiological processes. Glucose and lipid metabolism are the central pathways that maintain energy balance, thermal regulation, and control of the metabolome. Their dysfunction can cause metabolic diseases including obesity, diabetes, and mucolipidosis. The severity of these disorders can be diminished by the consumption of supplementary foods, such as capsaicin. However, the precise target of this supplementary dietary intake is not clearly understood because multiple tissues, such as adipose, pancreatic, and even CNS tissues may be modulated by these supplements. A systemic analysis would be required to reveal more of these mechanisms. Analysis of TRP channel mutated animals with regard to their metabolomes would help us to further understand TRP channel functions and related pathogenesis.
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###### 

Receptors, activators and inhibitors of metabolic TRP channels

  Subfamily   Locus                                                                               Activators                                                                                                                       Inhibitors                                                                          Functions                                                                                                                       References
  ----------- ----------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------- -----------------------------------------------------------------
  TRPV                                                                                                                                                                                                                                                                                                                                                                                                                                                 
   TRPV1      Sensory neurons, brain, spinal cord, keratinocytes, pancreas, tongue, and bladder   Cannabigerol, capsaicin, gingerol, lysophosphatidic acid, piperine, N-oleoyldopamine, palmitoylethanol-amide, and vanillotoxin   Capsazepine, iodo-resinifera toxin, resolvin D2 thapsigargin, yohimbine, and BCTC   Taste, salivary secretion, thermoregulation, intestinal ion and fluid secretion, gastric hormone release, and insulin release   ([@b14-molce-42-569]; [@b64-molce-42-569]; [@b74-molce-42-569])
   TRPV2      Brain, spinal cord, sensory neurons, spleen, and GI-tract                           Camphor, incensole acetate, and lysophosphatidylcholine                                                                          Tranilast                                                                           Thermoregulation, insulin release, and glucose homeostasis                                                                      ([@b67-molce-42-569])
   TRPV3      Brain, sensory neurons, and tongue                                                  Farnesyl pyrophosphate and menthol                                                                                               Isopentenyl pyrophosphate and resolvin D1                                           Taste, thermoregulation, and GI cancer                                                                                          ([@b3-molce-42-569]; [@b4-molce-42-569]; [@b53-molce-42-569])
   TRPV4      Brain, sensory neurons, kidney, heart, liver, spleen, and inner ear                 Citric acid, dimethylallyl pyrophosphate, apigenin, and 4α-phorbol 12, 13-de decanoate                                           Resolvin D1, HC-067047, and RN-1734                                                 Thermoregulation and pain                                                                                                       ([@b5-molce-42-569]; [@b79-molce-42-569])
  TRPM                                                                                                                                                                                                                                                                                                                                                                                                                                                 
   TRPM2      Brain, pancreas liver, and heart                                                    ADP-ribose and cyclic ADP-ribose                                                                                                 Clotrimazole, N-(p-amylcinnamoyl) anthranilic acid, and econazole                   Insulin secretion, diabetes, obesity, and CNS disorder                                                                          ([@b32-molce-42-569]; [@b66-molce-42-569])
   TRPM4      Pancreas, colon, bladder, and heart                                                 BTP2                                                                                                                             9-phenanthrol and flufenamic acid                                                   Insulin release and bladder function                                                                                            ([@b21-molce-42-569]; [@b81-molce-42-569])
   TRPM5      Brain, taste coil, pancreas, GI-tract, liver, and tongue                            Rutamarin and steviol glycosides                                                                                                 NSAID drugs, nicotine, tri-phenyl phosphine oxide, and 2-APB                        Taste, gastric hormone secretion, and insulin release                                                                           ([@b62-molce-42-569])
   TRPM8      Sensory neurons, liver, stomach, prostate, and bladder                              Menthol, linalool, geraniol, hydroxycitronellal, WS-3, and frescolat MGA                                                         AMTB, BCTC, benzimidazoles, and 5-benzyloxytrypamine                                Taste and thermoregulation                                                                                                      ([@b64-molce-42-569]; [@b65-molce-42-569])
  TRPA                                                                                                                                                                                                                                                                                                                                                                                                                                                 
   TRPA1      PNS, hair cells, and enter-endocrine cells                                          15-deoxy-Δ12, 14-PGJ2, 4-hydroxynonenal, 4-oxononenal, and methylglyoxal                                                         Camphor, menthol, resolvin D1, and resolvin D2                                      Taste, thermoregulation, and gastric hormone release                                                                            ([@b46-molce-42-569]; [@b100-molce-42-569])
   TRPML2     CNS, pancreas, and intracellular ion channels                                       SF-51, ML-SA1, SID24801657, and SID24787221                                                                                      Adenosine deaminase (ADA)                                                           Mucolipidosis                                                                                                                   ([@b75-molce-42-569])

Subfamilies of TRPA, TRPV, and TRPM are principal cationic channels having roles in body metabolism. TRP channels are regulated by various exogenous and endogenous activators and inhibitors. Their receptors and functions in metabolic aspects are listed.

BCTC, N-(4-Tertiarybutylphenyl)-4-(3-cholorphyridin-2-yl)tetrahydropyrazine-1(2H)-carbox-amide; GI, gastrointestinal; ADP, adenosine diphosphate; NSAID, nonsteroidal anti-inflammatory drug; AMTB, N-(3-Aminopropyl)-2-\[(3-methylphenyl)methoxy\]-N-(2-thienylmethyl)benzamide hydrochloride; MGA, menthone glycerin acetal; PNS, peripheral nervous system.

###### 

Involvement of TRP channels in each metabolic syndrome

  Subfamily   Receptor          Functions in obesity                                                                                                                                                                      Functions in diabetes                                                                                                         Functions in mucolipidosis                                                                                                                                    References
  ----------- ----------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------
  TRPV        TRPV1             Reduction in adipogenesis, appetite control, fat distribution, obesity-induced chronic inflammatory responses, and TRPV1 activation increase liver function                               Islets inflammation and insulin resistance, progression to T1DM                                                               \-                                                                                                                                                            ([@b104-molce-42-569])
              TRPV2             TRPV2 activation negatively regulate BAT differentiation, reduce lipid accumulation, KO mice has more WAT with HFD induced obesity                                                        TRPV2 inhibition cause glucose induced insulin secretion                                                                      \-                                                                                                                                                            ([@b79-molce-42-569]; [@b87-molce-42-569])
              TRPV3             Activation prevent lipid build-up and adipogenesis                                                                                                                                        \-                                                                                                                            \-                                                                                                                                                            ([@b13-molce-42-569])
              TRPV4             Regulate UPC1 level in subcutaneous adipose tissue, negatively regulate oxidative metabolism, TRPV4 KO protect from adipose inflammation, diet-mediated obesity, and insulin resistance   \-                                                                                                                            \-                                                                                                                                                            ([@b101-molce-42-569])
  TRPML       TRPML1 & TRPML2   \-                                                                                                                                                                                        \-                                                                                                                            *trpml* mutation causes pupal lethality, autophagy for nutrition, amino acid deprivation. Impairment in vascular carbohydrate, lipid and protein metabolism   ([@b90-molce-42-569])
  TRPM        TRPM2             TRPM2 KO are resistant to diet induced obesity and inflammation                                                                                                                           Increase calcium level, induce insulin secretion from pancreatic islets, KO reduce inflammation in adipose tissue and liver   \-                                                                                                                                                            ([@b105-molce-42-569])
              TRPM3             \-                                                                                                                                                                                        Regulate zinc level, trigger insulin secretion from beta-cells                                                                \-                                                                                                                                                            ([@b15-molce-42-569])
              TRPM4             \-                                                                                                                                                                                        Glucagon synthesis from alpha cells, indirect role in insulin synthesis                                                       \-                                                                                                                                                            ([@b15-molce-42-569])
              TRPM5             Basic taste regulator, control appetite and obesity                                                                                                                                       Increase insulin secretion and glucose tolerance, regulate plasma insulin level                                               \-                                                                                                                                                            ([@b62-molce-42-569])
              TRPM6             \-                                                                                                                                                                                        Balance serum magnesium level, reduce possibility of T2DM                                                                     \-                                                                                                                                                            ([@b91-molce-42-569])
              TRPM8             TRPM8 activation induces browning of WAT, induces UPC1 expression in BAT                                                                                                                  \-                                                                                                                            \-                                                                                                                                                            ([@b72-molce-42-569])
  TRPA        TRPA1             Activation cause satiety and control obesity                                                                                                                                              Activation induce insulin secretion from beta cells                                                                           \-                                                                                                                                                            ([@b46-molce-42-569])

This table provides specific TRP channels associated with obesity, diabetes, and mucolipidosis.

T1DM, type 1 diabetes mellitus; HFD, high fat diet.
